Abstract
Gastrin-releasing peptide (GRP) and GRP-related peptides are putative growth factors. Existence of GRP-like immunoreactivity (IR) has not been examined in bronchioalveolar secretions of the neonate. We have analyzed bronchial fluid of 54 premature infants (26-33 weeks of gest.) with severe RDS (FiO2 > 0.8, mechanical ventilation). Sequential samples (n = 290) were obtained within 1 week after surfactant (S) replacement therapy (single or multiple doses; total amount of phospholipids 200 vs. 400 mg/kg bw). GRP-like IR was determined by radioimmunoassay. Results: In 32/54 patients (59%) GRP-like IR could be detected. Concentrations were 0,3-70 ng/mg albumin (a). Neither gestational age, birthweight, sex nor severity of pulmonary disease did correlate with the amount of GRP-like IR detected. In 13/24 samples (54%) of single-dose-S-treated infants GRP-like IR was found (x = 3,16 ng/mg a); in multiple treated infants 18/30 probes (60%) were GRP-positive (x = 4,47 ng/mg a). Further HPLC characterization of the GRP-like IR suggests the existence of different molecular forms of GRP-like peptides. Conclusions: GRP-like IR can be detected in bronchial fluid of premature infants with severe RDS. Multiple doses of surfactant do not influence the GRP content. The physiological role of GRP-like peptides in the developing respiratory tract of the neonate has not been defined yet.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Choudhury, A., Nustede, R., Schmidt, W. et al. 163 GRP-LIKE IMMUNOREACTIVITY IN BRONCHIAL SECRETIONS OF SURFACTANT-TREATED PHEMATURE INFANTS WITH SEVERE RESPIRATORY DISTRESS SYNDROME (RDS). Pediatr Res 30, 655 (1991). https://doi.org/10.1203/00006450-199112000-00193
Issue Date:
DOI: https://doi.org/10.1203/00006450-199112000-00193